Predicted protein targets (top 10)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | AKT2 | P31751 | 18/20 | 0.68 |
| ▸ | AURKA | O14965 | 1/20 | 0.46 |
| ▸ | CYP2C9 | P11712 | 2/20 | 0.44 |
| ▸ | ROCK2 | O75116 | 2/20 | 0.44 |
| ▸ | AKT1 | P31749 | 3/20 | 0.44 |
| ▸ | ENPP1 | P22413 | 1/20 | 0.44 |
| ▸ | CYP2D6 | P10635 | 1/20 | 0.44 |
| ▸ | RPS6KB1 | P23443 | 1/20 | 0.44 |
| ▸ | GSK3B | P49841 | 1/20 | 0.44 |
| ▸ | AKT3 | Q9Y243 | 1/20 | 0.44 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL3920839 | 0.90 | AKT2 (0.84) | AKT2AURKACYP2C9ROCK2AKT1 | |
| SCHEMBL1002386 | 0.83 | AKT2 (0.77) | AKT2CYP2C9ROCK2AKT1CYP2D6 | |
| SCHEMBL1003331 | 0.81 | AKT2 (1.00) | AKT2CYP2C9ROCK2AKT1CYP2D6 | |
| SCHEMBL1788285 | 0.72 | L3MBTL1 (0.61) | AKT2AKT1RPS6KB1GSK3B | |
| SCHEMBL4076276 | 0.72 | AKT2 (0.69) | AKT2CYP2C9AKT1CYP2D6RPS6KB1 | |
| SCHEMBL1001861 | 0.72 | AKT2 (1.00) | AKT2CYP2C9ROCK2AKT1CYP2D6 | |
| SCHEMBL3492035 | 0.71 | AKT2 (0.53) | AKT2CYP2C9ROCK2AKT1ENPP1 | |
| SCHEMBL3993935 | 0.70 | AKT2 (0.76) | AKT2CYP2C9ROCK2AKT1CYP2D6 | |
| SCHEMBL5672420 | 0.70 | TTBK1 (0.47) | AKT2AKT1CYP2D6 | |
| SCHEMBL3488883 | 0.70 | AKT2 (0.49) | AKT2CYP2C9ROCK2AKT1GSK3B |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-2037931-A2 | PHARMACEUTICAL COMBINATIONS OF PK INHIBITORS AND OTHER ACTIVE AGENTS | Astex Therapeutics Limited (GB) | 2009-03-25 | — | — | EP | disclosed |
| WO-2007125310-A2 | PHARMACEUTICAL COMBINATIONS OF PK INHIBITORS AND OTHER ACTIVE AGENTS | ASTEX THERAPEUTICS LIMITED (GB) | 2007-11-08 | — | — | WO | disclosed |